MMEDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as MMEDV
MiniMed Group, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026
$17.79+0.30 (+1.72%)
Close on Oct 19, 2026
- Market cap
- $5.00B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$17.76 (+59,200%)past year
Weekly closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MiniMed Group, Inc. grew revenue 14.3% to $3.10B over the twelve months to Apr 24, 2026. Free cash flow was -$420.00M.
Revenue
$3.10B
+14.3% vs. a year earlier
Operating income
-$190.00M
TTM Q4 2026
Free cash flow
-$420.00M
TTM Q4 2026
EPS, diluted
-$1.30
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $5.00B
- P/E ratio
- –
- Price to sales
- 1.61
- Price to book
- 1.38
- Dividend yield
- –
- Free cash flow yield
- -8.40%
Fundamentals
- Revenue
- $3.10B
- Net income
- -$333.00M
- EPS, diluted
- -$1.30
- Free cash flow
- -$420.00M
- Book value per share
- $12.88
- Diluted shares
- 281M
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
$3.10B+14.3% YoY
Gross profit
$1.68B+9.9% YoY
Operating income
-$190.00M
Net income
-$333.00M
EPS, diluted
-$1.30
Free cash flow
-$420.00M
Reported period